Breuer, O.; Brodin, O.; Razaghi, A.; Brodin, D.; Gammelgaard, B.; Björnstedt, M.
Intravenous Infusion of High Dose Selenite in End-Stage Cancer Patients: Analysis of Systemic Exposure to Selenite and Seleno-Metabolites. Biomedicines 2023, 11, 295.
https://doi.org/10.3390/biomedicines11020295
AMA Style
Breuer O, Brodin O, Razaghi A, Brodin D, Gammelgaard B, Björnstedt M.
Intravenous Infusion of High Dose Selenite in End-Stage Cancer Patients: Analysis of Systemic Exposure to Selenite and Seleno-Metabolites. Biomedicines. 2023; 11(2):295.
https://doi.org/10.3390/biomedicines11020295
Chicago/Turabian Style
Breuer, Olof, Ola Brodin, Ali Razaghi, David Brodin, Bente Gammelgaard, and Mikael Björnstedt.
2023. "Intravenous Infusion of High Dose Selenite in End-Stage Cancer Patients: Analysis of Systemic Exposure to Selenite and Seleno-Metabolites" Biomedicines 11, no. 2: 295.
https://doi.org/10.3390/biomedicines11020295
APA Style
Breuer, O., Brodin, O., Razaghi, A., Brodin, D., Gammelgaard, B., & Björnstedt, M.
(2023). Intravenous Infusion of High Dose Selenite in End-Stage Cancer Patients: Analysis of Systemic Exposure to Selenite and Seleno-Metabolites. Biomedicines, 11(2), 295.
https://doi.org/10.3390/biomedicines11020295